That'll be to push the shareprice along for the next cap raise....

That'll be to push the shareprice along for the next cap raise. Hoping that with the new vastly improved operating costs and pulse revenue building that we are only looking at a modest raise this time. I'm not confident about the American CT pipeline right now, Cooper is correct, the NIH has been decimated by DOGE and there isnt much appetite in the US for medical research expenditure.

The companies that are doing the most growth at the minute are ones that offer affordable alternatives to healthcare (eg HIMS has doubled this year).
We will eventually fit that profile once we have enough units made so the long term future is still bright, but the short term is looking once again like a game of cat and mouse